Chris de Graaf

Chris de Graaf has a strong background in computational chemistry, with experience in both academic and industry settings. Chris is currently working at Sosei Heptares as a Senior Director and Head of Computational Chemistry since April 2022. Prior to this, they held the position of Director and Head of Computational Chemistry at Heptares Therapeutics from April 2018 to April 2022.

Before their industry roles, Chris worked at VU University Amsterdam as an Assistant Professor from December 2008 to March 2018. In this role, they were responsible for leading the computer-aided drug design research line and was involved in lecturing and supervising PhD students. Their research primarily focused on the development and application of computer-aided drug design methodologies to study protein-ligand interactions.

Chris also gained valuable experience during their postdoctoral fellowship at Université Louis Pasteur Strasbourg/AstraZeneca from February 2006 to November 2008. Prior to that, they completed their PhD at Vrije Universiteit Amsterdam from January 2002 to January 2006.

Overall, Chris de Graaf has a significant history of expertise and leadership in computational chemistry, contributing to both academic research and industry advancements in the field.

Chris de Graaf obtained a PhD in Pharmaceutical Sciences/Computational Chemistry from Vrije Universiteit Amsterdam (VU Amsterdam) between 2002 and 2006. Prior to that, they completed their MSc in Environmental Chemistry/Computational Chemistry at the University of Amsterdam from 1997 to 2002. Their earlier education includes attending Eerste Christelijk Lyceum (ECL) Haarlem where they completed VWO (gymnasium), although specific dates for this education were not provided.